Tectonic Therapeutic (TECX) Return on Capital Employed (2018 - 2026)
Tectonic Therapeutic's (TECX) quarterly Return on Capital Employed came in at 38.63% in Q1 2026, down 19.22% on a QoQ basis from 32.4% in Q4 2025.
Tectonic Therapeutic (TECX) Return on Capital Employed (2018 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 9 years of Return on Capital Employed data on file, last reported at 38.63% in Q1 2026.
- On a quarterly basis, Return on Capital Employed changed N/A year-over-year to 38.63% in Q1 2026; TTM through Mar 2026 was 38.63%, a N/A change from a year earlier, with the FY2025 full-year figure at 42.59%, up 2603.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 38.63%, down from 32.4% in the prior quarter.
- Over the last five years, Return on Capital Employed for TECX reached as high as 25.28% in Q2 2025 and fell as low as 162.42% in Q4 2023.
- Historically, Return on Capital Employed has averaged 67.62% across 5 years, with a median of 65.61% in 2023.
- Across the five-year window, Return on Capital Employed slumped 6065 bps in 2023 and surged 12353 bps in 2024, its largest moves.
- Year by year, Return on Capital Employed stood at 101.76% in 2022, then sank by 60 bps to 162.42% in 2023, then soared by 76 bps to 38.89% in 2024, then climbed by 17 bps to 32.4% in 2025, then dropped by 19 bps to 38.63% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 38.63% in Q1 2026, 32.4% in Q4 2025, and 27.64% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Tectonic Therapeutic | 595.23 Mn | 595.23 Mn | - | -38.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.63% |
| Dec 31, 2025 | -32.40% |
| Sep 30, 2025 | -27.64% |
| Jun 30, 2025 | -25.28% |
| Dec 31, 2024 | -38.89% |
| Sep 30, 2024 | -32.56% |
| Jun 30, 2024 | -37.46% |
| Mar 31, 2024 | -69.09% |
| Dec 31, 2023 | -162.42% |
| Sep 30, 2023 | -62.14% |
| Jun 30, 2023 | -86.91% |
| Mar 31, 2023 | -127.86% |
| Dec 31, 2022 | -101.76% |
| Sep 30, 2022 | -88.87% |
| Jun 30, 2022 | -79.57% |
| Mar 31, 2022 | -70.38% |
| Dec 31, 2021 | -62.30% |
| Sep 30, 2021 | -58.17% |
| Jun 30, 2021 | -54.67% |
| Mar 31, 2021 | -49.03% |